ContraVir Pharmaceuticals Inc. (Nasdaq: CTRV) priced its public offering of approximately 4.9 million common shares and warrants at the discounted price of $1.42 per unit sending the stock price plummeting 40 cents to close at $1.27.
ContraVir Pharmaceuticals prices offering at discount
March 30, 2016 at 16:31 PM EDT
